Lin Yu-ting cleared to return to women’s boxing competition

Olympic champion Lin Yu-ting has been cleared to compete in women’s boxing after World Boxing verified she met the organisation’s new eligibility criteria. The 30-year-old Taiwanese boxer, who won women’s featherweight gold for Chinese Taipei at the 2024 Paris Olympics, had become caught up in a prominent qualification controversy alongside Algeria’s Imane Khelif. Both boxers were formerly banned from the 2023 World Championships by the International Boxing Association, which pointed to failure to meet female competition requirements. World Boxing, which took over governance of the sport at Olympic competition level after the IOC’s removal of the IBA, introduced compulsory sex screening in August 2025. Lin’s approval comes after a completed appeal process and medical review by World Boxing’s impartial specialists.

The eligibility dispute that shook the Olympic boxing world

Lin Yu-ting’s clearance represents a major milestone in one of Olympic sport’s most controversial qualification controversies. The dispute emerged when the IBA excluded both Lin and Khelif from the 2023 World Championship event, claiming they had not satisfied the criteria for participation in women’s events. In spite of this rejection, Lin proceeded to secure Olympic gold in Paris just months later, performing under IOC supervision after the regulatory authority revoked the IBA of its status due to serious integrity and governance concerns. The affair exposed deep divisions within boxing governance and posed difficult questions about testing for eligibility and equity in women’s sport.

The disagreement amplified the examination regarding qualification standards in women’s boxing at the highest levels of competition. Lin’s absence from many tournaments following the governing body’s adoption of compulsory gender testing in August 2025 demonstrated the ambiguity regarding her status. The review mechanism, whilst thorough and eventually cleared the boxer, illustrated the personal and occupational strain of sustained status uncertainty. World Boxing’s choice to introduce objective medical evaluation systems constituted an effort to create clearer, more transparent standards for the activity moving forward.

• IBA excluded Lin and Khelif from 2023 World Championships
• IOC stripped IBA over governance failures and integrity concerns
• Lin won Olympic gold despite eligibility row in Paris
• World Boxing established compulsory sex testing in August 2025

World Boxing updated testing protocol explained

World Boxing’s compulsory sex screening policy, established in August 2025, constitutes a significant change in how the sport handles eligibility verification. The new regime centres on a specific genetic test intended to determine biological sex through scientific evaluation, superseding the former approach that had sparked considerable debate. This approach aims to provide objective, measurable criteria that World Boxing argues will safeguard both sporting integrity and competitor welfare. The policy applies to all competitors in women’s categories and includes a structured appeal process, enabling competitors to challenge initial results with accompanying medical documentation. This structure is intended to establish consistency and transparency across international boxing events.

The rollout of required testing procedures has proved significant for athletes like Lin Yu-ting, who encountered sustained doubt whilst the updated protocol was introduced. World Boxing’s decision to include an autonomous medical evaluation mechanism indicates understanding of the complexity surrounding eligibility determinations. The appeals mechanism permits boxers to present thorough clinical evidence for assessment by World Boxing’s Medical Committee, guaranteeing that personal situations get adequate attention. This fair-minded strategy seeks to merge clinical precision with process equity, acknowledging that biological sex cannot always be clearly defined. The governing authority underlines that the policy’s primary objective is upholding competitive integrity whilst safeguarding competitor protections and dignity throughout the verification process.

How the SRY genetic test operates

The SRY gene test operates by establishing the presence of a specific gene that World Boxing identifies as an marker for male biological sex. The test analyses genetic material to determine whether the Y chromosome is detected, which generally defines male development. According to World Boxing, this genetic marker offers an scientifically measurable indicator that can support eligibility decisions. The test constitutes a shift to scientific approach in determining sex determination, distinguishing itself from previous approaches that depended on different criteria. Results are evaluated by independent medical professionals who examine the findings within broader clinical context.

Athletes who test positive for the SRY gene are not immediately disqualified; instead, they enter an appeal process allowing them to submit further medical evidence. World Boxing’s Medical Committee examines all submitted documentation comprehensively before determining final eligibility decisions. This appeals mechanism recognises that genetic testing by itself may not provide the full biological picture, especially for athletes with conditions impacting sex development. The assessment process considers medical history, hormonal levels, and other relevant clinical factors in conjunction with genetic results. This multi-faceted approach aims to ensure that determinations are scientifically sound and individually appropriate rather than determined solely on individual test outcomes.

• Reveals Y chromosome presence confirming male biological sex
• Positive results initiate standalone clinical assessment appeal process
• Clinical Panel assesses genetic and clinical evidence thoroughly

The appeals process and medical evidence

Following an initial screening in 2025, the Chinese Taipei Boxing Association launched a formal appeal on Lin’s behalf, providing detailed medical evidence to World Boxing for impartial examination. The appeals process is a critical safeguard within World Boxing’s eligibility framework, allowing athletes to challenge original screening outcomes by providing supporting clinical evidence. This mechanism acknowledges that biological sex determination is multifaceted and that genetic markers alone cannot tell the complete story of an individual’s medical history and physiology. The CTBA’s choice to advance the challenge demonstrated confidence in Lin’s case and dedication to exonerating her through proper channels.

The provision of medical documents marked a pivotal moment in the determination of Lin’s competitive standing. World Boxing’s medical specialists conducted a comprehensive assessment of all evidence presented, considering not only genetic test results but also wider medical considerations such as hormone levels, clinical background, and additional pertinent physiological data. This comprehensive approach guaranteed that the decision was grounded in complete medical assessment rather than isolated test results. The stringent examination procedure underscored World Boxing’s commitment to determining outcomes that are scientifically robust and individually appropriate, whilst maintaining the standards of women’s competition.

What the medical committee concluded

The World Boxing Medical Committee concluded that Lin had been female since birth and met all requirements for participation in the female category, with no competitive advantage. This determination followed thorough assessment of the clinical evidence and constituted a final settlement to the eligibility question that had overshadowed her career since the 2023 World Championships. The committee’s determination upheld Lin’s right to compete at the top tier of women’s boxing, clearing the path for her return to international competition.

What lies ahead for Lin and female boxing

Lin’s clearance constitutes a major milestone not only for her career but for women’s boxing in general. The 30-year-old can now resume competing in competitions sanctioned by World Boxing after sitting out numerous competitions since the compulsory sex testing requirement was introduced in August 2025. Her return represents a possibility of regaining her status as a two-time world title holder and expand upon her Olympic gold medal from Paris. The resolution also offers resolution for the Chinese Taipei Boxing Association, which has consistently backed Lin throughout the disputed eligibility proceedings and welcomed the validation of her status.

The case carries broader implications for how international sports bodies approach eligibility policies and competitor wellbeing. World Boxing’s choice to establish a thorough appeals mechanism with independent medical review sets a precedent for balancing competitive integrity with individual fairness. As Lin gets ready to compete to the ring, her return to competition will be carefully monitored by the professional boxing world and beyond, potentially influencing how other sporting bodies create and improve their own eligibility frameworks. The way ahead underscores the significance of comprehensive, open procedures that respect both the scientific aspects of sex testing and the human dignity of athletes.

• Lin can now take part in all World Boxing-sanctioned global tournaments with no limitations.
• The appeals procedure showcases World Boxing’s commitment to equitable, fact-based qualification assessments.
• Her comeback strengthens trust in women’s boxing oversight within the new regulatory system.